Genetically predicted higher circulating IL-1β was inversely associated with LUAD and LUSC, and was suggestively associated with decreased lung cancer risk after adjusting for genetically predicted effects of IL-1α and IL-Ra, without pleiotropy identified. Here, IL1B is linked to lung carcinoma.